News
Osisko gibt vorläufige Lieferungen für Q2 2023 und Unternehmensupdate bekannt
Montréal, 6. Juli , 2023 - Osisko Gold Royalties Ltd. (das "Unternehmen" oder "Osisko") (OR: TSX & NYSE) - https://www.commodity-tv.com/ondemand/companies/profil/osisko-gold-royalties-ltd/
Rockstone Research – SPEKTAKULÄR GIGANTISCHE DIMENSIONEN: Lake Winn erhält geophysikalische Signaturen von bis zu 7 km Länge und 100 m Breite auf seinem LNPG-Lithiumprojekt in NWT
Der Riese ist wach und wartet auf die Bohrungen im Sommer!
Das Bild in der Mitte oben zeigt das QMAGT-System von Dias Geophysical, "ein hubschraubergestütztes Vermessungssystem, das das
Could Meta Be Risking Another Sell Off With Its New "Threads"?
Mark Zuckerberg has started a battle on more than one front. He has chosen not only the company that has most effectively dominated short-form written content but also an adversary known to be a
2 Must-Have Specialized ETFs for the Long-Term Investor
Constructing a long-term investment portfolio can be a lot like building a house.
First, you pour in the foundation. These are the tried and true pillars that have been around for decades — and
High-Yield Bassett Furniture Rocks Into Reversal
The furniture industry has struggled, but indications from Bassett Furniture (NASDAQ: BSET) echo news from other furniture manufacturers and have the shares rocketing higher. The takeaway is that
New Name, Coherent is a Compelling AI Data Infrastructure Play
Laser systems maker Coherent Co. (NASDAQ: COHR) changed its name from II-VI, confusing investors even trying to pronounce the name. The company is undergoing a multi-year restructuring plan to
Is It Time to Get into Piedmont Lithium Pre-Production?
Development-stage integrated lithium company Piedmont Lithium Inc. (NYSE: PLL) stock has been trading in an ever tighter trading range. Lithium is crucial for operating electric vehicles (EVs) as
Yield Curve Tests New Lows, Where Markets Are Seeking Safety
As markets come to a significant turning point, investors can benefit from understanding where money has been and where it may be going into, as pivots in the flow of investment preferences
$1 Billion Deal For Moderna To Expand Product Pipeline in China
The defensive stocks sector has been underperforming most - if not all - of the remaining cyclical sectors in the U.S. economy. These preferences come from underlying dynamics in the money markets
Kopin Corp is the Technology Seen Behind Smart AR Glasses
High-resolution microdisplay maker Kopin Co. (NASDAQ: KOPN) stock is still trading down over 80% from its $13.62 post-COVID highs in 2021. The business has improved since then, but shares are
National Beverage Corp. Underperforms Buy These Stocks Instead
National Beverage Corp. (NASDAQ: FIZZ) stock has outperformed other beverage companies since the pandemic bottom and even in 2023, but that is about to change. The company offers little reason to
Eilt: Durchbruch im Kampf gegen Hautkrebs - Massives Kaufsignal. Neuer 217% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 217% mit Biotech Aktientip Vida
Eilt: Durchbruch im Kampf gegen Hautkrebs - Massives Kaufsignal. Neuer 217% Biotech Aktientip nach 15.973% mit BioNTech
06.07.23 08:02
London (www.aktiencheck.de , Anzeige)
3 Russell 2000 Stocks to Buy as Small-Caps Make a Comeback
The Russell 2000 Index (INDEXRUSSELL: RUT) is a market index made up of 2,000 small-cap companies. The companies in the index make up the bottom two-thirds of company size in the Russell 3000
These Banks Are Boosting Dividends After Safe Stress Tests
After the collapse of Silicon Valley Bank (NASDAQ: SIVB) a few months ago, regional and larger banks across the United States saw their stocks decline as a systematic reaction to the news. As is a
Three (3) Stocks Under $10 That Insiders Are Buying
Insider buying is almost always a good signal that a stock is undervalued, and today’s list includes 3 that also trade for less than $10 per share. The takeaway is that Comtech Telecommunications
3 Cash-Rich Defensive Companies Making Investors Rich
The phrase “cash is king” can mean several different things depending on perspective.
To a local restaurant that only accepts cash payments, ‘cash is king.’ To investors in an overheated stock
Amazon Is Having Its Best Run In Years, But Should You Chase It?
With fellow tech heavyweights like Apple Inc (NASDAQ: AAPL), Meta Inc (NASDAQ: META), and Alphabet Inc (NASDAQ: GOOGL) all seeing strong rallies this year, it should be no surprise that Amazon Inc
Is The XLE Primed For A Potential Breakout?
The Energy Select Sector SPDR Fund (NYSE: XLE) is setting up on a higher time frame for a potential breakout. YTD, the sector ETF is down almost 7%. However, as the uptrend remains intact and the
Next-Gen AI Datacenters Driving Applied Digital Stock up 400%
Next-generation data center solutions provider Applied Digital Co. (NASDAQ: APLD) stock exploded higher by over 400% in 2023. The company designs, constructs and operates high-performance
3 (AI) Plays That Could Rocket Higher In Q3
AI spending is set to explode. The analysts can’t agree on the final figures but agree on one thing: the numbers will be huge. One industry, the grocery industry, if you can believe it, is
EV Makers Deliver Big...What it Means for Their Stocks
Global vehicle electrification is going full speed ahead.
A fleet of electric vehicle (EV) manufacturers provided monthly and quarterly updates over the weekend that can be summed up in one word
Goldman Sachs Reportedly Mulling Apple Card Move To Amex
The Goldman Sachs Group (NYSE: GS) is reportedly in talks with American Express Co. (NYSE: AXP) regarding its Apple Inc. (NASDAQ: AAPL) credit card and other consumer-focused products connected
Moderna Announces Global Regulatory Submissions for Its Respiratory Syncytial Virus (RSV) Vaccine, MRNA-1345
- Moderna has submitted marketing authorization applications for the investigational RSV vaccine, mRNA-1345, with the European Medicines Agency, Swissmedic, and the Therapeutic Goods
Moderna kündigt weltweite Zulassungsanträge für seinen Impfstoff MRNA-1345 gegen das Respiratorische Synzytial-Virus (RSV) an
- Moderna hat Zulassungsanträge für den RSV-Prüfimpfstoff mRNA-1345 bei der Europäischen Arzneimittelagentur, bei Swissmedic und bei der Therapeutic Goods Administration in
Eilt: Erstklassige Studienergebnisse im Kampf gegen Hautkrebs. Neuer 217% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 217% mit Biotech Aktientip Vidac
Eilt: Erstklassige Studienergebnisse im Kampf gegen Hautkrebs. Neuer 217% Biotech Hot Stock nach 134.452% mit Biogen
05.07.23 08:17
London (www.aktiencheck.de, Anzeige)